CD93 and cancer: To fully analyze the differential expression of CD93 between normal and tumor samples as compelling a manner as possible, we integrated the data of the TCGA and GTEx databases and found that they were still differentially expressed in many cancers, most of which were consistent with the previous analysis (Figure 1D).